After a pause under the Saving on a Valuable Education (SAVE) program, the U.S. Department of Education is resuming student ...
On track to initiate TRX319 Phase 1/2a dose-escalation trial in early 2026TRX319 is an allogeneic CAR-Tr1 Treg cell therapy designed to pair ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results